Table 1.
Baseline demographics for study population. Values are numbers (percentages) unless stated otherwise
| Characteristics | Total MI (n=283 014) | STEMI (n=95 176) | NSTEMI (n=187 838) |
|---|---|---|---|
| Mean (SD) age (years) | 71.7 (12.2) | 69.1 (12.5) | 73.0 (11.8) |
| Men | 180 205 (64) | 63 119 (66) | 117 086 (62) |
| Women | 102 809 (36) | 32 057 (34) | 70 752 (38) |
| Mean (SD) BMI | 26.7 (5.9) | 26.6 (7.1) | 26.8 (5.2) |
| Mean (SD) eGFR | 68.2 (24.1) | 73.4 (23.1) | 65.8 (24.2) |
| Current smoker | 55 673 (20) | 24 531 (26) | 31 142 (17) |
| Medical history | |||
| Diabetes | 61 955 (22) | 15 806 (17) | 46 149 (25) |
| Hypertension | 123 436 (44) | 36 306 (38) | 87 130 (46) |
| Coronary artery disease | 100 638 (36) | 21 280 (22) | 79 358 (42) |
| Myocardial infarction | 91 283 (32) | 19 345 (20) | 71 938 (38) |
| PCI | 32 846 (12) | 7574 (8) | 25 272 (13) |
| CABG | 23 971 (8) | 3711 (4) | 20 260 (11) |
| Chronic heart failure | 3373 (1) | 573 (1) | 2800 (1) |
| Stroke | 17 116 (6) | 3935 (4) | 13 181 (7) |
| Drugs at admittance | |||
| β -blockers | 120 904 (43) | 29 851 (31) | 91 053 (48) |
| Calcium antagonist | 51 107 (18) | 13 603 (14) | 37 504 (20) |
| Aspirin | 123 647 (44) | 29 258 (31) | 94 389 (50) |
| ACE-I/ARB | 88 592 (31) | 20 955 (22) | 67 637 (36) |
| Statins | 75 381 (27) | 16 978 (18) | 58 403 (31) |
Diuretics
87
367 (31)
19
180 (20)
68
187 (36)
MI=myocardial infarction; STEMI=ST elevation myocardial infarction; NSTEMI=non-ST elevation myocardial infarction; BMI=body mass index; eGFR=estimated glomerular filtration rate; PCI=percutaneous coronary intervention; CABG=coronary artery bypass graft; ACE-I/ARB=angiotensin converting enzyme inhibitor/angiotensin receptor blocker